HealthlineHealth Agency Reports from CDC, FDA, and NIH Halted by Trump Officials

The Trump administration has implemented an immediate pause on public communications from federal health agencies, including the CDC, FDA, and NIH. This temporary measure affects various aspects of public health communication, from regulatory updates to press releases, with exceptions permitted for critical health and safety matters.

Key Points:

• The Department of Health and Human Services issued a directive halting multiple forms of public communication, including regulations, announcements, press releases, and social media posts. The pause will remain in effect until approved by a political appointee.
• The CDC’s Morbidity and Mortality Weekly Report (MMWR), a critical publication for sharing health information and recommendations, falls under this communication freeze. This impacts the dissemination of time-sensitive public health updates and disease surveillance data.
• NIH operations have experienced significant disruption, particularly affecting grant reviews and council meetings where research funding decisions are typically made. This has created uncertainty for academic medical centers and ongoing clinical trials.
• The FDA maintains some critical communications, such as their ongoing list of recalls and urgent drug safety warnings, though these updates may face additional scrutiny under the new directive.
• Although temporary pauses during administrative transitions are standard practice, this post-inauguration halt has raised concerns among public health experts about potential delays in communicating critical health information to healthcare providers and the public.

“Not a day goes by when CDC isn’t tracking a potential threat to our health”
— Richard Besser, MD, former acting director of the CDC

More on Politics & Medicine